Ticker Details
ADC Therapeutics SA
IPO Date:	May 18, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$127.23M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.38 | 4.23%
Avg Daily Range (30 D):	$0.04 | 3.75%
Avg Daily Range (90 D):	$0.09 | 4.52%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.99M
Avg Daily Volume (90 D):	1.45M

Trade Size
Avg Trade Size (Sh.):	145
Avg Trade Size (Sh.) (30 D):	198
Avg Trade Size (Sh.) (90 D):	186

Institutional Trades
Total Institutional Trades:	363
Avg Institutional Trade:	$1.35M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$1.12M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.91M
Avg Closing Trade (30 D):	$.57M
Avg Closing Trade (90 D):	$1.05M
Avg Closing Volume:	499.67K

News

Jan 13, 2026 @ 9:58 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:50 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire

May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.6	$-.11	$-.21
Diluted EPS	$-.6	$-.11	$-.21
Revenue	$79.58M	$19.25M	$20.85M
Gross Profit
Net Income / Loss	$-96.91M	$-16.57M	$-32.97M
Operating Income / Loss	$-99.55M	$-25.41M	$-25.25M
Cost of Revenue
Net Cash Flow	$-45.45M	$-11.9M	$-30.33M
PE Ratio

Splits
May 10, 2005	1:7